Mks Instruments (MKSI) 35.94 $MKSI MKS Instruments'

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mks Instruments (MKSI) 35.94 $MKSI

MKS Instruments' (MKSI) CEO Gerald Colella on Q1 2015 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 12:10PM CDT

MKSI: 35.94 (+0.44)

MKS Instruments Q1 Earnings Beat on Semiconductor Trade - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 23, 10:40AM CDT
MKS Instruments, Inc. (MKSI) reported robust first-quarter 2015 results, with both revenues and adjusted earnings surpassing the respective year-ago tallies as well as Zacks Consensus Estimates.
COHU: 10.56 (-0.09), RTEC: 12.38 (-0.07), MKSI: 35.94 (+0.44), AAPL: 130.28 (+0.61)

MKS Instruments beats 1Q profit forecasts
Automated Insights - Wed Apr 22, 4:38PM CDT
ANDOVER, Mass. (AP) _ MKS Instruments Inc. (MKSI) on Wednesday reported first-quarter net income of $33.8 million.
MKSI: 35.94 (+0.44)

MKS Instruments beats by $0.13, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 3:34PM CDT

MKSI: 35.94 (+0.44)

MKS Instruments Reports Q1 2015 Financial Results
GlobeNewswire - Wed Apr 22, 3:30PM CDT
MKS Instruments, Inc. (Nasdaq:MKSI), a global provider of technologies that enable advanced processes and improve productivity; today reports first quarter 2015 financial results.
MKSI: 35.94 (+0.44)

Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 4:35PM CDT

SKX: 89.66 (+2.79), SLG: 128.82 (+1.47), AMP: 127.75 (+0.58), CTXS: 66.99 (-0.35), WSTC: 32.20 (-0.01), SLM: 10.25 (+0.02), CAKE: 52.98 (+0.56), WFT: 14.16 (-0.05), TYL: 132.12 (+1.82), FFIV: 123.18 (+0.78), LOGI: 15.01 (-0.47), MKSI: 35.94 (+0.44), FTK: 14.06 (-0.43), AHL: 47.77 (-0.09), TMK: 56.09 (-0.11), HNI: 51.98 (+0.71), FOE: 12.62 (unch), FB: 81.53 (-0.88), PLCM: 12.94 (-0.15), CLB: 124.69 (-0.63), XLNX: 42.88 (-0.88), RJF: 57.06 (-0.50), TXN: 54.73 (+0.01), AF: 13.05 (-0.06), VMI: 124.44 (+1.30), CCI: 85.98 (-0.66), OII: 54.10 (-1.47), CLW: 64.38 (+0.21), AFOP: 19.33 (-0.43), SGMO: 14.70 (-0.84), LVS: 55.25 (+0.13), AWH: 41.69 (-0.02), TSCO: 90.98 (-0.28), USTR: 42.07 (-0.28), CVA: 20.97 (-0.40), T: 34.01 (-0.22), EBAY: 59.20 (+0.31), IBKC: 62.86 (-0.61), CNMD: 53.40 (-0.83), QCOM: 68.24 (-0.10), PLXS: 44.20 (-0.32), BDN: 15.00 (+0.35), SUSQ: 13.40 (-0.01), NEU: 461.52 (-7.91), GGG: 71.11 (-1.09), ORLY: 229.35 (+1.04), CYS: 9.15 (+0.05), LHO: 38.40 (-0.10), EFX: 98.49 (+0.09), CUB: 50.07 (-0.15), ALGT: 168.12 (+1.10), TCBI: 51.61 (-0.61), SCSS: 34.50 (+0.86), CLGX: 39.45 (+0.23), IGT: 20.21 (+0.21)

MKS Instruments (MKSI) Passes Through 2% Yield Mark
DividendChannel.com - Fri Apr 17, 2:57PM CDT
Looking at the universe of stocks we cover at Dividend Channel, in trading on Friday, shares of MKS Instruments, Inc. were yielding above the 2% mark based on its quarterly dividend (annualized to $0.66), with the stock changing hands as low as...
MKSI: 35.94 (+0.44)

Dividend Challengers (And Near-Challengers): 55 Increases Expected By June 30
David Fish - at Seeking Alpha - Thu Apr 16, 2:31AM CDT

NBL: 50.49 (-1.02), AIN: 40.49 (unch), LXP: 9.59 (-0.03), LM: 54.60 (+0.07), WBS: 35.96 (-0.13), CNL: 54.51 (-0.07), FFIN: 28.85 (-0.44), NOV: 54.20 (-1.55), LYB: 100.83 (+3.26), NSP: 50.80 (-0.91), MKSI: 35.94 (+0.44), HWCC: 9.56 (-0.09), HNI: 51.98 (+0.71), IVZ: 40.82 (+0.01), EXR: 67.61 (+0.28), POR: 37.12 (+0.39), AME: 52.33 (-0.36), BRS: 59.92 (-1.89), FNV: 49.24 (-1.07), SXT: 68.00 (-1.16), EE: 38.59 (+0.30), TG: 20.61 (+0.12), OII: 54.10 (-1.47), PCAR: 66.14 (-0.35), UNH: 118.69 (+0.43), POOL: 67.59 (-2.44), PPS: 56.89 (-0.12), M: 66.99 (-0.43), AWK: 55.45 (+0.82), HFC: 39.76 (+1.26), AWH: 41.69 (-0.02), HUM: 182.35 (+0.44), TSCO: 90.98 (-0.28), WHR: 196.49 (+5.57), LII: 108.00 (+0.75), JNS: 18.51 (unch), AVY: 51.91 (+0.40), MNRK: 12.28 (+0.05), BK: 42.07 (-0.51), MEOH: 57.96 (+1.88), LAD: 107.06 (+2.15), DVN: 66.50 (+0.20), BBOX: 19.76 (-0.04), XEC: 121.51 (-2.18), MAN: 85.15 (+1.51), LHO: 38.40 (-0.10), MAR: 81.84 (+0.49), POPE: 66.80 (+1.30), WINA: 89.09 (+1.36), TAXI: 10.51 (+0.05), OMC: 77.50 (-0.30), CE: 65.85 (+0.75), BAX: 71.14 (-0.37), VIAB: 70.74 (+0.04), LXK: 43.22 (-1.26)

Insider Trading Alert - CZNC, SNCR And MKSI Traded By Insiders
at The Street - Wed Apr 08, 10:00AM CDT
Stocks with insider trader activity include CZNC, SNCR and MKSI
SNCR: 51.48 (-0.44), CZNC: 20.34 (+0.08), MKSI: 35.94 (+0.44)

MKS Instruments Announces First Quarter 2015 Earnings Conference Call
GlobeNewswire - Tue Apr 07, 8:00AM CDT
MKS Instruments, Inc. (Nasdaq:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that it will release first quarter 2015 financial results after market close on Wednesday, April 22, 2015. A conference call with management will be held on Thursday, April 23, 2015 at 8:30 a.m. (EDT). To participate in the conference call, please dial (877) 212-6076 for domestic callers and (707) 287-9331 for international callers, and an operator will connect you. Participants will need to provide the operator with the Conference ID of 14695327, which has been reserved for this call. A live and archived webcast of the call will be available on the company's website at www.mksinst.com.
MKSI: 35.94 (+0.44)

Axcelis (ACLS) Up to Strong Buy on Q4 Results & Order Wins - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 31, 12:00PM CDT
Zacks Investment Research upgraded Axcelis Technologies Inc. (ACLS) to a Zacks Rank #1 (Strong Buy) on Mar 31, 2015.
TSRA: 38.40 (-1.17), RTEC: 12.38 (-0.07), MKSI: 35.94 (+0.44), ACLS: 2.62 (-0.03)

Notable Two Hundred Day Moving Average Cross - MKSI
DividendChannel.com - Thu Mar 26, 10:39AM CDT
In trading on Thursday, shares of MKS Instruments, Inc. crossed below their 200 day moving average of $34.04, changing hands as low as $33.32 per share.
MKSI: 35.94 (+0.44)

Insider Trading Alert - MKSI, BCRX And CSGS Traded By Insiders
at The Street - Mon Mar 23, 10:45AM CDT
Stocks with insider trader activity include MKSI, BCRX and CSGS
BCRX: 10.35 (-0.18), CSGS: 29.82 (-0.05), MKSI: 35.94 (+0.44)

MKS Instruments Rides on Growth Trajectory, Runs Risks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 11:40AM CDT
On Mar 16, we issued an updated research report on premium technology company, MKS Instruments, Inc. (MKSI).
KLIC: 15.49 (-0.19), RTEC: 12.38 (-0.07), SPIL: 8.26 (-0.02), MKSI: 35.94 (+0.44)

MKS Acquires Precisive, LLC
GlobeNewswire - Wed Mar 18, 8:00AM CDT
MKS Instruments, Inc. (Nasdaq:MKSI), a global provider of technologies that enable advanced processes and improve productivity, announces the acquisition of Precisive, LLC, for $13 million in an all-cash transaction that closed yesterday.
MKSI: 35.94 (+0.44)

Dividend Challengers (And Near-Challengers): 51 Increases Expected By May 30
David Fish - at Seeking Alpha - Sun Mar 15, 5:57AM CDT

NBL: 50.49 (-1.02), BBT: 37.78 (-0.08), PDCO: 48.19 (+0.70), CNL: 54.51 (-0.07), NSU: 3.82 (+0.03), WBS: 35.96 (-0.13), LYB: 100.83 (+3.26), NSP: 50.80 (-0.91), SCS: 18.69 (+0.18), MKSI: 35.94 (+0.44), INDB: 41.78 (-0.17), MOV: 31.17 (+0.28), TMK: 56.09 (-0.11), HWCC: 9.56 (-0.09), HNI: 51.98 (+0.71), ISCA: 36.55 (-0.40), IVZ: 40.82 (+0.01), SIG: 138.00 (+0.02), STWD: 24.27 (+0.10), IEX: 75.89 (-0.48), FCZA: 11.08 (+0.20), SXT: 68.00 (-1.16), MELI: 137.48 (-1.49), UDR: 33.51 (+0.17), OII: 54.10 (-1.47), PCAR: 66.14 (-0.35), POOL: 67.59 (-2.44), OXM: 79.94 (-0.16), AWK: 55.45 (+0.82), WSM: 76.91 (+0.22), TSCO: 90.98 (-0.28), WHR: 196.49 (+5.57), JNS: 18.51 (unch), MNRK: 12.28 (+0.05), BK: 42.07 (-0.51), LAD: 107.06 (+2.15), XEC: 121.51 (-2.18), MAN: 85.15 (+1.51), MAR: 81.84 (+0.49), POPE: 66.80 (+1.30), WINA: 89.09 (+1.36), TAXI: 10.51 (+0.05), ABB: 21.69 (-0.14), CE: 65.85 (+0.75), LXK: 43.22 (-1.26)

MKS Fortifies Product Range on New Gas Analysis System - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 11, 4:20PM CDT
Premium multinational technology company, MKS Instruments, Inc. (MKSI) recently strengthened its product portfolio by launching the Cirrus(TM) 3-XD Atmospheric gas analysis arrangement in both rack-mounted and benchtop models.
KLIC: 15.49 (-0.19), RTEC: 12.38 (-0.07), SPIL: 8.26 (-0.02), MKSI: 35.94 (+0.44)

MKS Introduces the Cirrus(TM) 3-XD Atmospheric Gas Analysis System
GlobeNewswire - Tue Mar 10, 8:00AM CDT
MKS Instruments, Inc. (Nasdaq:MKSI), a global provider of technologies that enable advanced processes and improve productivity, has introduced the Cirrus(TM) 3-XD Atmospheric gas analysis system in both benchtop and rack mounted models. These quadrupole mass spectrometer (QMS) based systems provide a step-change in performance and 'eXtreme Detection' capability to advance atmospheric gas analysis in a wide range of analytical applications and environments. The Cirrus 3-XD system features new, patented V-lens(TM) Ion Optics Technology that eliminates baseline noise associated with the effects of metastable neutrals (a by-product of bulk gas ionization), a common issue in conventional QMS instruments. This unique performance attribute enables users, for the first time, to achieve consistently low ppb level detection limits, irrespective of the bulk gas present. The compact system includes new software to streamline the process of carrying out accurate quantitation of trace and bulk gases, and a unique capillary inlet and oven design that ensures a rapid and ultra-stable response.
MKSI: 35.94 (+0.44)

MKS Instruments to Present at the BofA - Merrill Lynch Smid Cap Conference
GlobeNewswire - Tue Mar 03, 8:00AM CST
MKS Instruments, Inc. (Nasdaq:MKSI), a global provider of technologies that enable advanced processes and improve productivity, announced today that it will present at the BofA - Merrill Lynch Smid Cap Conference at the Four Seasons Hotel, Boston, MA on Tuesday, March 17, 2015 at 1:35 p.m. (Eastern Time). The presentation will be webcast live and will be available for a limited time in the Investor Relations section of the company's website at www.mksinst.com.
MKSI: 35.94 (+0.44)

MKS Instruments (MKSI): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 7:38AM CST
MKS Instruments (MKSI) in the Electrical – Manufacturing Machinery space is seeing solid earnings estimate revisions and has a great Zacks Industry Rank.
MKSI: 35.94 (+0.44)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Adobe’s Recent Options Activity Results

Updated Category News Views 114

Adobe's Options Activity Highlights In the world of finance, significant trades often signal important market sentiments. Recently, major investors have moved toward a bearish outlook on Adobe. Analyzing the options history for Adobe (NASDAQ: ADBE), we've identified a total of 67 significant trades. Our insights reveal that approximately 41% of these trades have been...

Continue Reading
Indonesia's Ongoing Challenge with Chinese Maritime Presence

Updated Category News Views 130

Indonesia's Maritime Security Efforts Intensify Recently, Indonesia's maritime security has been under increased scrutiny as incidents involving a Chinese coast guard vessel continue to escalate. This week, a Chinese vessel was driven from Indonesian waters not once, but twice, after interfering with a critical energy survey conducted by Pertamina, the state energy...

Continue Reading
Revolutionizing Game Development with Upheaval Games' Dreamer Portal

Updated Category News Views 140

Welcome to the Future of Game Development Upheaval Games, founded by veterans from the gaming industry, embraces a new frontier in game design with the introduction of The Dreamer Portal. This innovative web-based interface allows creators to effortlessly build immersive game content with just a simple prompt. Imagine the power of crafting unique creatures, items, and...

Continue Reading
Alvotech Moves Forward with Gobivaz® Approval in Europe

Updated Category News Views 190

Alvotech and Advanz Pharma Collaborate for Biosimilar Approval REYKJAVIK and LONDON – Alvotech (NASDAQ: ALVO), a renowned biotechnology firm, along with Advanz Pharma, a leading global pharmaceutical company, has shared important news regarding the marketing approval of Gobivaz®, a proposed biosimilar to Simponi® (golimumab). This biologic treatment is designed for...

Continue Reading
Exploring the Growth Potential of Remote Patient Monitoring Sector

Updated Category News Views 181

Remote Patient Monitoring Set for Dynamic Growth The increasing prevalence of chronic conditions worldwide is expected to significantly accelerate the growth of the remote patient monitoring (RPM) market. As conditions like hypertension, diabetes, and cardiovascular diseases become more common, coupled with an aging population, healthcare systems face immense pressure to...

Continue Reading